General Information of the Protein
Protein ID
PT01726
Protein Name
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A
Secondarily
Protein Name
61 kDa Cam-PDE
hCam-1
Gene Name
PDE1A
Sequence
MGSSATEIEELENTTFKYLTGEQTEKMWQRLKGILRCLVKQLERGDVNVVDLKKNIEYAASVLEAVYIDETRRLLDTEDELSDIQTDSVPSEVRDWLASTFTRKMGMTKKKPEEKPKFRSIVHAVQAGIFVERMYRKTYHMVGLAYPAAVIVTLKDVDKWSFDVFALNEASGEHSLKFMIYELFTRYDLINRFKIPVSCLITFAEALEVGYSKYKNPYHNLIHAADVTQTVHYIMLHTGIMHWLTELEILAMVFAAAIHDYEHTGTTNNFHIQTRSDVAILYNDRSVLENHHVSAAYRLMQEEEMNILINLSKDDWRDLRNLVIEMVLSTDMSGHFQQIKNIRNSLQQPEGIDRAKTMSLILHAADISHPAKSWKLHYRWTMALMEEFFLQGDKEAELGLPFSPLCDRKSTMVAQSQIGFIDFIVEPTFSLLTDSTEKIVIPLIEEASKAETSSYVASSSTTIVGLHIADALRRSNTKGSMSDGSYSPDYSLAAVDLKSFKNNLVDIIQQNKERWKELAAQEARTSSQKCEFIHQ
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Phosphodiesterase
>
Phosphodiesterase 1
>
Phosphodiesterase 1A
Function
Calcium/calmodulin-dependent cyclic nucleotide phosphodiesterase with a dual specificity for the second messengers cGMP and cAMP, which are key regulators of many important physiological processes. Has a higher efficiency with cGMP compared to cAMP.
    Show/Hide
Uniprot ID
Primary ID:
P54750

Secondarily ID:
D3DPG5
Q86VZ0
Q9C0K8
Q9C0K9
Q9C0L0
Q9C0L1
Q9C0L2
Q9C0L3
Q9C0L4
Q9UFX3
    Show/Hide
Ensembl ID
ENSG00000115252
HGNC ID
HGNC:8774
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000013 , Sf9
Compound ID Compound Name Compound Formula
CP0013428
N-[(1S)-1-[3-fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl]-7-methoxy-2-oxo-1,3-dihydropyrido[2,3-b]pyrazine-4-carboxamide
   Show/Hide
C19H18F4N4O5
 1
1
IC50 = 2497 nM
   TI
   LI
   LO
   TS
CP0000847
(2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11(16),12,14-tetraene-4,7-dione
   Show/Hide
C22H19N3O4
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0176508
[4-[3-(3-fluoro-4-methoxyphenyl)-5-(2-methylphenyl)-3,4-dihydropyrazol-2-yl]phenyl]-(4-methylpiperazin-1-yl)methanone
   Show/Hide
C29H31FN4O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0365459
[4-[5-tert-butyl-3-(3,5-difluoro-4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]phenyl]-(4-methylpiperazin-1-yl)methanone
   Show/Hide
C26H32F2N4O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0444327
[4-[3-(4-methoxyphenyl)-5-(2-methylphenyl)-3,4-dihydropyrazol-2-yl]phenyl]-(4-methylpiperazin-1-yl)methanone
   Show/Hide
C29H32N4O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0419692
N-(2-hydroxyethyl)-4-[3-(4-methoxyphenyl)-5-(2-methylphenyl)-3,4-dihydropyrazol-2-yl]benzamide
   Show/Hide
C26H27N3O3
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0419693
[4-[5-tert-butyl-3-(2,3-difluoro-4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]phenyl]-(4-methylpiperazin-1-yl)methanone
   Show/Hide
C26H32F2N4O2
 1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0109248
(2S,8R)-2-(5-bromothiophen-2-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
   Show/Hide
C19H16BrN3O2S
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0109250
(2S,8R)-6-methyl-2-(5-methylthiophen-2-yl)-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
   Show/Hide
C20H19N3O2S
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0144390
(2S,8R)-2-(5-ethylfuran-2-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
   Show/Hide
C21H21N3O3
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0157968
(10S,15S)-13-ethyl-10-(5-methylfuran-2-yl)-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
   Show/Hide
C20H19N3O3
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0157969
(10S,15S)-13-ethyl-10-(5-ethylthiophen-2-yl)-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
   Show/Hide
C21H21N3O2S
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0164472
(10S,15R)-13-ethyl-10-(5-ethylthiophen-2-yl)-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
   Show/Hide
C21H21N3O2S
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0168902
(10S,15R)-13-ethyl-10-(5-ethylfuran-2-yl)-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
   Show/Hide
C21H21N3O3
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0257911
(10S,15S)-13-ethyl-10-(5-ethylfuran-2-yl)-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
   Show/Hide
C21H21N3O3
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0268684
(2S,8R)-2-(5-ethylthiophen-2-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
   Show/Hide
C21H21N3O2S
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0392073
(10S,15S)-13-butyl-10-(5-ethylthiophen-2-yl)-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
   Show/Hide
C23H25N3O2S
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0392075
(10R,15R)-13-ethyl-10-(5-ethylfuran-2-yl)-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
   Show/Hide
C21H21N3O3
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0392491
(2R,8S)-2-(5-ethylthiophen-2-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
   Show/Hide
C21H21N3O2S
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0432292
(10S,15R)-13-butyl-10-(5-ethylthiophen-2-yl)-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
   Show/Hide
C23H25N3O2S
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0440103
(10S,15S)-13-ethyl-10-(3-methylthiophen-2-yl)-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione
   Show/Hide
C20H19N3O2S
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Phosphodiesterase 1A (PDE1A) )
Target Type Literature-reported Target